Navigation Links
BEN in Medical Technology

Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture

...onsumers make 160 million decisions to purchase Unilever products. In the United States, the portfolio includes major brand icons such as: Axe, ben & Jerry's, Bertolli, Breyers, Caress, Country Crock, Degree, Dove personal care products, Hellmann's, Klondike, Knorr, Lipton, Popsicle, Promise, ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

...ared to coronary artery bypass graft (CABG) surgery. Total medical costs at one year were also lower with PCI. Analysis of the data was presented by ben van Hout, Ph.D., of the University of Utrecht, The Netherlands, at the annual EuroPCR Scientific Program in Barcelona. "This analysis demonstrate...

Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline

...Ltd Tel: +44-1799-532920 Dr Edward E. Hodgkin, CEO enquiries@biotica.com Financial Dynamics Tel: +44(0)20-7831-3113 ben Atwell Ben.Atwell@fd.com ...

Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer

...SA: HUYA China: Shenzhen Chipscreen Biosciences, Ltd. Jan Tuttleman, PhD ben Ni, PhD Vice President, Head of Xian-Ping LU, PhD Marketing Therapeutics President and Chief HUYA Bio...

Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease

...e work could lead to the initial validation of amyloid as a therapeutic target of interest and potential biomarker for PD-related cognitive decline. ben Schmand, PhD, of Academic Medical Center (The Netherlands) has been funded to extend an observational clinical study begun three years ago. His study ...

Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients

...just one to five treatment sessions. The Promise of RapidArc Using Varian's RapidArc radiotherapy technology in the treatment of brain tumors, ben Slotman, who is professor and chairman of the Department of Radiation Oncology at the VU University Medical Center in Amsterdam, Netherlands, said he ...

Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients

...Immune cell function testing for the optimization of the therapeutic drug monitoring in selected heart transplant patients, a case series" (T. ben Gal, V. Yaari, M. Israeli, et al.) -- poster presentation, 5:45 p.m. - 6:45 p.m. (General Posters: Poster Session II) Friday, April 11 -- "Succ...

Researchers Use Magnetism to Target Cells to Animal Arteries

..., Ph.D., Ivan S. Alferiev, Ph.D., and Darryl Williams, of Children's Hospital; Boris Polyak, M.D., and Gary Friedman, Ph.D., of Drexel University; and ben Yellen, Ph.D., of Duke University. About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as t...

YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country

...ures Samuel L. Jackson, Omarion, Kat DeLuna, Mekhi Pfifer, Elisha Cuthbert, Maria Menounos, Shannon Elizabeth, comedian Russell Peters, Kelly Rowland, ben Jelen, DJ Rekha, State Radio, Shotgun Honeymoon, Emmy Rossum, and more in PSAs, school visits, and/or special events across the country. Beginning t...

CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

Novagali Pharma Announces Positive Vekacia Clinical Results From Pivotal Phase III Trial in Vernal Keratoconjunctivitis

...cular allergy throughout Europe and Mediterranean area and lead by Pr David ben Ezra, Hadassah Hebrew University Hospital, Jerusalem, who first reported on...ought significant benefits even in severe forms of the disease" declared Pr ben Ezra, study lead investigator "It can confidently be said that now, the tre...

Independent publication supports the profile of CeNeS phase II compound, CNS 5161

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension

...rate the benefits of combining a renin inhibitor with a diuretic during its pilot clinical development programme of SPP100 between 2000-2002 [5]. Mr ben Tan, Speedel Head of Business Development & Licensing commented "In the antihypertensive drug market, the most commonly prescribed fixed combinati...

FDA approves IND on Lead Product M6G

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development ...

Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial Dynamics ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development an...
Other Tags
(Date:7/9/2014)... how a complex protein pivotal in the development of ... discovery answers a key question about one of the ... the subject of tens of thousands of research papers ... Zhang, a research student in Professor Sir Philip Cohen,s ... protein complex, called NF-κB, is activated. The results ...
(Date:7/9/2014)... associate professor of plant pathology and microbiology ... the 2014 Alexopoulos Prize by the Mycological ... the science of mycology the study of fungi ... plant pathogens, and medically important fungi. , The award ... mycologist. Stajich received the award last month in East ...
(Date:7/9/2014)... selection refers to species, selection for traits that are ... natural selection enhances opportunities to mate, the tail of ... the University of California, Riverside have now found that ... placenta are linked. Describing the life histories of ... Poeciliidae, the researchers found that species with placentas tend ...
Breaking Biology News(10 mins):Research reveals how key controller protein is switched on 2UC Riverside plant pathologist receives national recognition 2Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4
(Date:7/10/2014)... (Boston) Emergency Medical Service (EMS) responders felt better ... receiving focused tactical training according to a new study ... This is the first study to specifically examine the ... scene where a shooter has not yet been neutralized ... , Incidents such as the Columbine High School shooting, ...
(Date:7/10/2014)... baby" an infant seemingly cured of HIV that was reported ... infection in The New England Journal of Medicine ... two years of not taking antiretroviral therapy without evidence of ... in the case. , "Certainly, this is a ... staff involved in the child,s care, and the HIV/AIDS research ...
(Date:7/10/2014)... of Huddersfield could help to improve the quality of ... such as butter, mayonnaise, yoghurt and fruit drinks ... for her work. , Katerina gained her MSc degree ... now she has embarked on research for a PhD. ... is investigating the potential of carbohydrates extracted from the ...
(Date:7/10/2014)... men with localized prostate cancer were more likely ... received less effective treatments and survived for shorter ... depressed, a UCLA study has found. , The ... factors such as bias against the mentally ill, ... man,s lack of investment in his general health ...
(Date:7/9/2014)... DC (July 10, 2014) If you think winning is ... for kids think again: Winning along with other mental bonuses ... of which falls into one of 11 big fun factors, ... winning is all important when it comes to the "fun" ... and quantify what goes into this elusive conceptuntil now. , ...
Breaking Medicine News(10 mins):Health News:Active shooter training increases comfort level of emergency responders 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:World interest in research work on the benefits of the Okra plant 2Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 3
Other Contents